Bringing Digital Pathology to Life
APERIO TECHNOLOGIES EXPANDS OPERATIONS IN EUROPE
Company expands UK operations center to respond to growing demand for Digital Pathology in Europe; appoints European Sales Director
VISTA, CA – August 8, 2006 – Aperio Technologies, Inc., the leading provider of digital pathology systems and services to the healthcare IT industry, today announced that it has further expanded its operations in Europe with the opening of a new and larger operations center in Bristol, UK, and the appointment of Peter Rogan to lead its European sales efforts.
Aperio's new UK offices, located at The Sanctuary in Office Park, Ham Green, Bristol, UK BS20 0DD, will serve as a base of operations for sales, marketing, and business development activities throughout Europe, and will allow Aperio to meet the growing demand for digital pathology in Europe's progressive pathology laboratories.
"We see a burgeoning need for digital pathology around the world. As the leader in digital pathology, we are committed to offering this exciting technology to the finest teaching hospitals, research facilities, and pharmaceutical companies throughout Europe,' said Dirk Soenksen, CEO of Aperio Technologies. "We are also very pleased that Peter Rogan has joined our team to head Aperio's European operations, including sales. His extensive experience in microscopy and imaging equipment will be a great asset to our company.'
Prior to joining Aperio as European Sales Director, Rogan spent 18 years at Olympus UK, Ltd., a leading manufacturer of professional opto-digital products in the fields of microscopy and imaging. While at Olympus, he was responsible for directing the overall business development initiatives for the company's microscopy division, in addition to other important sales and marketing functions. Rogan holds specialized degrees in the area of laboratory sciences from Bridgewater School, Worsley, Manchester; Bolton Technical College; and Salford Technical College.
Rogan commented about his new appointment, "I look forward to working with the Aperio team to help pathology laboratories throughout Europe adopt this new technology. Digital pathology is transforming the way that pathologists capture, view, manage, share, and analyze pathology information. Aperio's digital pathology systems and services improve a pathologist's efficiency and productivity across many fronts, making people's lives easier and better. It is rewarding to be a part of that.'
Since the company's inception in 1999, Aperio has successfully installed approximately 200 digital pathology systems in 16 countries, worldwide. Aperio's European customer base includes several renowned healthcare, pharmaceutical, and educational organizations throughout the region, such as UK's AstraZeneca R&D and Leeds University; Novartis International Ag in West Sussex, England; University of Zurich in Switzerland; Uppsala University Hospital in Sweden; and Sanofi Aventis Histologie Moleculaire in France.
# # #
